5-Acetyl-2-hydroxybenzoic acid ethyl ester
M.F: C11H12O4
M.W: 205.07 |
|
|
Use : Pharmaceutical application. |
Development |
|
3-Amino-2-cyclohexene-1-one
Cas No: 5220-49-5
M.F: C6H9NO
M.W: 111.07 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
2-(2-Aminoethyl)-1-methylpyrrolidine
Cas No: 51387-90-7
M.F: C7H16N2
M.W: 128.22 |
|
|
Use : Pharmaceutical application.
Possible Intermediate for Udenafil |
Development |
|
2-Benzimidazole propionic acid
Cas No: 23249-97-0
M.F: C10H10N2O2
M.W: 190.07 |
|
|
Use : Pharmaceutical application.
Possible Intermediate for Procodazole |
Commercial |
|
3-Bromo-2-buten-1-ol
Cas No: 76334-36-6
M.F: C4H7BrO
M.W: 151 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
a-Bromocinnamaldehyde
Cas No: 5443-49-2
M.F: C9H7BrO
M.W: 209.97 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
4-Bromocinnamic acid
Cas No: 50663-21-3
M.F: C9H7BrO2
M.W: 227.05 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
3-Bromo-5-Chloro-2-hydroxyacetophenone
Cas No: 59443-15-1
M.F: C8H6BrClO2
M.W: 247.92 |
|
|
Use : Pharmaceutical application. |
Development |
|
3-Bromo-n,n-dimethyl aniline
Cas No: 16518-62-0
M.F: C8H10BrN
M.W: 200.08 |
|
|
Use : Pharmaceutical application. |
Development |
|
2-Bromoethylamine hydrobromide
Cas No: 2576-47-8
M.F: C2H7Br2N
M.W: 204.89 |
|
|
Use : Pharmaceutical application.
Possible Intermediate for Altanserin/Medazepam/Pyrimidifen |
Commercial |
|
n-(2-Bromoethyl)-4-fluorobenzamide
Cas No: 95383-37-2
M.F: C9H9BrFNO
M.W: 244.99 |
|
|
Use : Pharmaceutical application. |
Development |
|
2-Bromohexadecnoic acid
Cas No: 18263-25-7
M.F: C16H31BrO2
M.W: 334.15 |
|
|
Use : Pharmaceutical / Speciality application |
Commercial |
|
a-Bromo-g-butyrolactone
Cas No: 5061-21-2
M.F: C4H5BrO2
M.W: 163.95 |
|
|
Use : Pharmaceutical application. Possible Intermediate for Nebivolol/Spizofurone/Ofurace |
Commercial |
|
6-Bromopyridine-3-carboxaldehyde
Cas No: 149806-06-4
M.F: C6H4BrNO
M.W: 186.01 |
|
|
Use : Pharmaceutical application. |
Development |
|
5-Bromoquinoline
Cas No: 4964-71-0
M.F: C9H6BrN
M.W: 208.05 |
|
|
Use : Pharmaceutical application. |
Development |
|
3-Butoxycyclohex-2-en-1-one
Cas No: 16493-04-2
M.F: C10H14O2
M.W: 166.22 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
2-chloroethylisothiocyanate
Cas No: 6099-88-3
M.F: C3H4CINS
M.W: 121.59 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
6-Chloro-3-methyl uracil
Cas No: 4318-56-3
M.F: C5H5CIN2O2
M.W: 160.56 |
|
|
Use : Pharmaceutical application. |
Development |
|
2-Chlorophenylisothiocyanate
Cas No: 2740-81-0
M.F: C7H4CINS
M.W: 169.63
|
|
|
Use : Pharmaceutical application. |
Commercial |
|
4-Cyanobenzylamine hydrochloride
Cas No: 10406-25-4
M.F: C8H9CIN2
M.W: 168.62
|
|
|
Use : Pharmaceutical/Speciality application. |
Commercial |
|
Dibenzothiophene
Cas No: 132-65-0
M.F: C12H8S
M.W: 184.03 |
|
|
Use : Pharmaceutical / Speciality application. |
Commercial |
|
4,4-Dimethylcyclohexanone
Cas No: 4255-62-3
M.F: C8H14O2
M.W: 126.20 |
|
|
Use : Pharmaceutical/Speciality application. |
Commercial |
|
1,3-Dimethyl uracil
Cas No: 874-14-6
M.F: C6H8N2O2
M.W: 140.14 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Ethylacetamidocyanoacetate
Cas No: 4977-62-2
M.F: C7H10N2O3
M.W: 170.17 |
|
|
Use : Pharmaceutical application. Possible Intermediate for Lanreotide/Hypoxanthine/Cetrorelix/Tabimorelin |
Commercial |
|
Ethyl-5-bromo-benzofuran-2-carboxylate
Cas No: 84102-69-2
M.F: C11H9BrO3
M.W: 269.09 |
|
|
Use : Pharmaceutical application. |
Development |
|
Ethyl-7-bromo-benzofuran-2-carboxylate
Cas No: 1033201-65-8
M.F: C11H9BrO3
M.W: 269.09 |
|
|
Use : Pharmaceutical application. |
Development |
|
6-Fluoro-4-iodo-beta picoline
Cas No: 153034-94-7
M.F: C6H5FIN
M.W: 237.01 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
2-Fluoro-4-Iodo-5-Methyl Pyridine
Cas No: 153034-94-7
M.F: C6H5FIN
M.W: 237.01 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
3-Hydroxy-4-iodobenzoic acid
Cas No: 58123-77-6
M.F: C7H5IO2
M.W: 264.02 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
2-Isopropyl-4-Hydroxy anisole
Cas No: 13523-62-1
M.F: C10H14O2
M.W: 166.22 |
|
|
Use : Pharmaceutical application. |
Development |
|
2-Methoxuphenyl-2-oxazolin
M.F: C10H11NO2
M.W.177.20 |
|
|
Use : Pharmaceutical application. |
Development |
|
6-Methoxysalicylaldehyde
Cas No: 700-44-7
M.F: C8H8O3
M.W: 152.15 |
|
|
Use : Pharmaceutical application. |
Development |
|
Methyl Isovanillate
Cas No: 6702-50-7
M.F: C9H10O4
M.W: 182.17 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
3-Methylphenethyl alcohol
Cas No: 1875-89-4
M.F: C9H12O
M.W: 136.19 |
|
|
Use : Pharmaceutical application. |
Development |
|
Nonylamine
Cas No: 112-20-9
M.F: C9H21N
M.W: 143.27 |
|
|
Use : Pharmaceutical/Speciality application. |
Commercial |
|
(n-Octyl)-triphenylphosphonium bromide
Cas No: 42036-78-2
M.F: C26H32BrP
M.W: 455.41 |
|
|
Use : Pharmaceutical application. |
Development |
|
Phenylchlorothionoformate
Cas No: 1005-56-7
M.F: C7H5ClOS
M.W: 172.63 |
|
|
Use : Pharmaceutical application. Possible Intermediate for Cladribine/Torcitabine |
Commercial |
|
Pyridine-2,4-dicarboxylic acid
Cas No: 499-80-9
M.F: C7H5NO4
M.W: 167.12 |
|
|
Use : Pharmaceutical/Speciality application. |
Commercial |
|
5-(2-pyridyl)-2-pyridone
Cas No: 381233-78-9
M.F: C10H8N2O
M.W: 172.18 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Triethyl-3-methylphosphonocrotonate
Cas No: 41891-54-7
M.F: C11H20O5P-
M.W: 263.25 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Tri-tert-butylphosphonium tetrafluoroborate
Cas No: 131274-22-1
M.F: C12H28BF4P
M.W: 290.13 |
|
|
Use : Pharmaceutical application. |
Development |
|
Tris-(3-methoxyphenyl)phosphine
Cas No: 29949-84-6
M.F: C21H21O3P
M.W: 182.17 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Tris-(4-methoxyphenyl)phosphine
Cas No: 855-38-9
M.F: C21H21O3P
M.W: 182.17 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Tris-(2-tolyl)phosphine
Cas No: 6163-58-2
M.F: C21H21P
M.W: 304.37 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Tris-(3-tolyl)Phosphine
Cas No: 6224-63-1
M.F: C21H21P
M.W: 304.37 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Tris-(4-tolyl)Phosphine
Cas No: 1038-95-5
M.F: C21H21P
M.W: 304.37 |
|
|
Use : Pharmaceutical application. |
Commercial |
|
Troger's base
Cas No: 529-81-7
M.F: C17H18N2
M.W: 250.34 |
|
|
Use : Pharmaceutical/Speciality application. |
Commercial |
|
Acetals 
